Healthcare Analysts discuss what is new and on the horizon (relevant companies ANTX INSM MNKD SPRO) for treatment of the Non-Tuberculosis Mycobacteria Lung Disease on an Analyst/Industry conference call to be held on February 24.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANTX: